Related Experiment Videos
Quantitative evaluation of postembolized splenic tissue using technetium-99m sulfur colloid.
Clinical Nuclear Medicine
|April 1, 1987
Summary
Technetium-99m sulfur colloid scans accurately quantify residual splenic tissue after partial splenic embolization (PSE). This nuclear medicine technique precisely measures spleen volume reduction in hypersplenism patients, outperforming CT and MRI.
Area of Science:
- Nuclear Medicine
- Radiology
- Transplant Surgery
Background:
- Hypersplenism can complicate renal transplant outcomes.
- Partial splenic embolization (PSE) is a treatment option for hypersplenism.
- Accurate quantification of splenic tissue post-PSE is crucial for assessing treatment efficacy.
Purpose of the Study:
- To evaluate the accuracy of Technetium-99m sulfur colloid scintigraphy in quantifying residual splenic tissue after PSE.
- To compare the precision of this nuclear medicine technique with computed tomography (CT) and magnetic resonance imaging (MRI).
Main Methods:
- Developed and validated a liver-spleen phantom simulating human anatomy for Tc-99m sulfur colloid imaging.
- Utilized lucite pseudo-emboli to precisely displace known volumes within the spleen phantom.
- Analyzed computer-generated images from the phantom and 17 renal transplant patients undergoing PSE.
Main Results:
- A high correlation (0.996, P < 0.001) was found between actual displaced splenic volume and computer-estimated values.
- The Tc-99m sulfur colloid scan technique demonstrated superior precision compared to CT and MRI.
- The nuclear medicine method was less complex to perform than CT or MRI for this specific measurement.
Conclusions:
- Tc-99m sulfur colloid scintigraphy provides a precise and reliable method for quantifying residual splenic tissue post-PSE.
- This technique offers advantages in accuracy and ease of performance over CT and MRI for assessing post-embolization splenic volume.
- Accurate splenic volume assessment aids in managing hypersplenism in renal transplant recipients.